Is Poly Medicure Ltd (POLYMED) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Poly Medicure Ltd is a good quality company .

Is Poly Medicure Ltd (POLYMED) undervalued or overvalued?

The key valuation ratios of Poly Medicure Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Poly Medicure Ltd (POLYMED) share price return in the past 10 years?

Poly Medicure Ltd share price has appreciated 26.1% annually (CAGR) over the past ten years.

Is Poly Medicure Ltd (POLYMED) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Poly Medicure Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the share price of Poly Medicure Ltd (POLYMED)?

Company share prices are keep on changing according to the market conditions. The current trading price of Poly Medicure Ltd (POLYMED) on 17-Apr-2026 16:59:59 at 16:59 is 1468.25.

What is the P/E ratio of Poly Medicure?

The latest standalone P/E ratio of Poly Medicure as of 17-Apr-2026 is 43.51.

What is the P/B ratio of Poly Medicure Ltd (POLYMED)?

The latest standalone P/B ratio of Poly Medicure Ltd (POLYMED) as of 17-Apr-2026 is 5.02.

What is the 52-week high and low of Poly Medicure Ltd (POLYMED)?

The 52-week high of Poly Medicure Ltd (POLYMED) is Rs. 2936.70 and the 52-week low is Rs. 1184.00.

Poly Medicure Ltd (POLYMED) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Poly Medicure Ltd (POLYMED)
Brand: Poly Medicure

Poly Medicure Ltd (POLYMED) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Poly Medicure Ltd (POLYMED)

BSE: 531768 NSE: POLYMED

Key Metrics

Market Cap

₹14,882 Cr.

P/E Ratio

43.51

Price to Book (P/B)

5.02

Price to Sales (P/S)

9.07

EV/EBITDA

26.24

Return on Capital Employed (ROCE)

20.14%

Current Price

₹1,468.3

Return on Equity (ROE)

15.79%

Return on Assets (ROA)

12.94%

Operating Profit Margin

27.9%

Net Profit Margin

20.69%

Gross Profit Margin

32.6%

Book Value per Share

₹292.7

Sales Growth (YoY)

22.53%

Sales Growth (3 Years)

22.13%

Operating Profit Growth (1 Year)

27.43%

Operating Profit Growth (3 Years)

27.9%

Net Profit Growth (1 Year)

31.63%

52-Week Low / High

₹1,184 / 2,937

Net Profit Growth (3 Years)

31.41%

Dividend Yield

0.16%

Promoter Holding

62.42%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Poly Medicure Ltd?

Poly Medicure Ltd revenue growth is 22.5% for FY-2025 , which is above its 5 year CAGR of 19.9% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Poly Medicure Ltd?

Promoters hold 62.42% of the Poly Medicure Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Poly Medicure Ltd vs industry peers?

Poly Medicure Ltd revenue CAGR is 19.91% , compared to the industry median CAGR of 1.45% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Poly Medicure Ltd belong to?

Poly Medicure Ltd belongs to the Healthcare sector, operating specifically within the Medical Equipment/Supplies/Accessories segment.

Q.1 Stock return of Poly Medicure Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 26.1% based on the current price.

DeciZen - make an informed investing decision on Poly Medicure

Based on:

Data

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation

3. Price Trend

Poly Medicure stock performance

Key Ratios

Is Poly Medicure Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	26.1%	25.3%	26%	22.9%	24.6%	21.6%	17.7%	19.3%	23.3%	20.1%	-
Value Creation Index ⓘ	0.9	0.8	0.9	0.6	0.8	0.6	0.3	0.4	0.7	0.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	394	440	508	587	646	747	879	1,068	1,307	1,602	1,640
Sales YoY Gr.	-	11.4%	15.7%	15.4%	10.1%	15.7%	17.7%	21.5%	22.4%	22.5%	-
Adj EPS ⓘ	5	5.6	7.1	6.9	9.6	12.9	14.3	17.9	25	31.2	33.7
YoY Gr.	-	12.4%	27.1%	-3.1%	39.4%	34%	10.7%	25.6%	39.6%	24.6%	-
BVPS (₹) ⓘ	25.4	30.5	37.9	43	48.6	99.4	112.1	128.4	151.6	270.6	292.7
Adj Net Profit ⓘ	44	49.5	62.9	60.9	85	124	137	172	240	316	342
Cash Flow from Ops. ⓘ	61.9	55	75.5	113	127	116	126	197	256	237	-
Debt/CF from Ops. ⓘ	1.3	1.8	1.7	1.3	1.5	1.1	0.9	0.7	0.6	0.7	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	16.9%	19.9%	22.1%	22.5%
Adj EPS ⓘ	22.6%	26.5%	29.8%	24.6%
BVPSⓘ	30.1%	41%	34.1%	78.5%
Share Price	26.1%	10.9%	16.5%	-38.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	21.2	20.1	20.8	17.1	21	17.9	13.5	14.9	17.8	15	12
Op. Profit Mgn % ⓘ	21.9	21.4	23.9	22.8	25.1	28.2	24.3	25.3	26.9	27.9	26.9
Net Profit Mgn % ⓘ	11.2	11.3	12.4	10.4	13.2	16.5	15.6	16.1	18.4	19.7	20.9
Debt to Equity ⓘ	0.4	0.4	0.4	0.4	0.4	0.1	0.1	0.1	0.1	0.1	-
Working Cap Days ⓘ	144	146	157	159	173	182	177	173	167	165	198
Cash Conv. Cycle ⓘ	67	75	80	80	78	78	89	92	87	93	156

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	33.7	34.3
TTM Sales (₹ Cr.)	1,640	1,782
BVPS (₹) ⓘ	292.7	294.7
Reserves (₹ Cr.) ⓘ	2,916	2,937
P/BV ⓘ	5.02	4.98
PE ⓘ	43.51	42.80

From the Market
52 Week Low / High (₹)	1184.00 / 2936.70
All Time Low / High (₹)	0.50 / 3350.00
Market Cap (₹ Cr.)	14,882
Equity (₹ Cr.)	50.7
Face Value (₹)	5
Industry PE ⓘ	163.7

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Poly Medicure - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	394	439	508	587	646	747	879	1,068	1,307	1,602
Operating Expenses ⓘ +	308	345	387	453	484	537	665	802	956	1,154
Manufacturing Costs	100	113	131	143	153	162	200	243	276	337
Material Costs	107	110	121	152	153	197	261	300	364	424
Employee Cost	69	81	94	110	127	131	150	188	229	280
Other Costs ⓘ	33	41	41	48	51	47	54	70	88	113
Operating Profit ⓘ	86	94	122	134	162	210	214	266	351	447
Operating Profit Margin (%)	21.9%	21.4%	23.9%	22.8%	25.1%	28.1%	24.3%	24.9%	26.9%	27.9%
Other Income ⓘ +	8	14	14	16	19	19	39	36	58	90
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	10	8	11	13	20	10	5	10	13	14
Depreciation ⓘ	20	23	28	36	39	46	53	56	62	81
Profit Before Tax ⓘ	65	76	96	100	122	173	195	237	335	443
Tax ⓘ	18	20	26	34	29	44	49	58	83	112
Profit After Tax	47	56	70	66	92	130	146	179	252	331
PAT Margin (%)	12.0%	12.8%	13.8%	11.3%	14.3%	17.3%	16.6%	16.8%	19.3%	20.7%
Adjusted EPS (₹)	5.4	6.4	8.0	7.5	10.5	13.5	15.2	18.7	26.2	32.7
Dividend Payout Ratio (%)	28%	39%	25%	27%	19%	19%	16%	16%	11%	11%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	224	269	334	379	429	953	1,075	1,232	1,455	2,742
Share Capital ⓘ	22	44	44	44	44	48	48	48	48	51
Reserves ⓘ	202	225	290	335	385	905	1,027	1,184	1,407	2,691
Debt +	61	76	106	127	155	91	81	112	146	167
Long Term Debt	31	48	79	91	111	60	31	12	1	0
Short Term Debt	30	28	27	35	44	31	50	101	145	167
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	30	41	43	50	60	56	78	78	89	77
Others Liabilities ⓘ	61	63	71	105	128	131	100	173	204	242
Total Liabilities ⓘ	376	449	555	661	772	1,231	1,334	1,596	1,894	3,228
Fixed Assets
Net Fixed Assets ⓘ +	177	200	256	269	324	385	447	597	831	1,047
Gross Block	288	333	417	461	550	655	764	963	1,255	1,536
Accumulated Depreciation	111	133	161	192	226	270	317	365	424	489
CWIP ⓘ	14	20	18	19	25	21	43	78	71	93
Investments ⓘ	6	6	18	42	58	385	384	181	221	1,127
Inventories	41	58	69	74	101	109	150	183	193	250
Trade Receivables	81	95	112	124	120	149	191	221	259	340
Cash Equivalents	21	22	20	53	22	27	8	171	137	143
Others Assets ⓘ	37	47	61	80	122	154	110	165	183	227
Total Assets ⓘ	376	449	555	661	772	1,231	1,334	1,596	1,894	3,228

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	62	55	75	113	127	116	126	197	256	237
PBT ⓘ	65	76	96	100	122	173	195	237	335	443
Adjustment ⓘ	25	22	38	41	50	45	39	60	36	36
Changes in Working Capital ⓘ	-14	-25	-36	-1	-10	-58	-60	-42	-41	-154
Tax Paid ⓘ	-14	-18	-23	-27	-36	-44	-47	-58	-74	-89
Cash Flow From Investing Activity ⓘ +	-30	-54	-87	-104	-106	-434	-89	-189	-237	-1,191
Capex	-31	-55	-81	-45	-104	-93	-150	-237	-269	-324
Net Investments	-1	-2	-8	-62	-7	-344	57	48	20	-882
Others ⓘ	2	3	2	3	5	3	4	0	12	15
Cash Flow From Financing Activity ⓘ +	-31	-1	14	-10	-22	319	-40	-8	-17	953
Net Proceeds from Shares ⓘ	0	0	0	0	0	400	0	0	0	1,000
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-8	-7	-9	-12	-9	-8	-4	-8	-10	-11
Dividend Paid ⓘ	-27	-13	-5	-21	-42	0	-24	-24	-29	-30
Others ⓘ	4	19	29	23	30	-73	-12	24	22	-6
Net Cash Flow ⓘ	1	0	3	-1	-1	1	-2	-0	2	-2

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	22.75	22.81	23.28	18.58	22.85	18.74	14.4	15.52	18.74	15.79
ROCE (%)	26.14	25.3	25.96	22.92	24.64	21.62	17.68	19.34	23.28	20.14
Asset Turnover Ratio	1.1	1.08	1.02	0.97	0.91	0.75	0.69	0.73	0.75	0.63
PAT to CFO Conversion(x)	1.32	0.98	1.07	1.71	1.38	0.89	0.86	1.1	1.02	0.72
Working Capital Days
Receivable Days	64	72	74	73	69	65	70	70	67	68
Inventory Days	43	40	45	44	49	51	54	57	52	50
Payable Days	116	117	127	112	131	108	94	95	84	71

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Poly Medicure Ltd FAQs

The current trading price of Poly Medicure on 17-Apr-2026 16:59 is ₹1,468.3.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Poly Medicure stood at ₹14,882.1 Cr

The latest P/E ratio of Poly Medicure as of 16-Apr-2026 is 43.51.

The latest P/B ratio of Poly Medicure as of 16-Apr-2026 is 5.02.

The 52-week high of Poly Medicure is ₹2,936.7 and the 52-week low is ₹1,184.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Poly Medicure is ₹1,640 ( Cr.) .

About Poly Medicure Ltd

Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products.

POLYMED manufactures its products using state of the art technology in ultra modern facilities covering over 300,000 square feet of manufacturing floor space with about 50,000 square feet of clean rooms of class 100,000 to class 1,000. A tool room with modern facilities & CNC machines supports the manufacturing processes. A high degree of automation and an effective process control helps in delivering consistent product quality.

To keep pace with the ever changing requirements of the market, POLYMED has a fully staffed and highly equipped R & D section to design and develop new and innovative products. Using the latest CAD/CAM technology, the new product development is fast and improvements, based on market response and customer feedback, are made with ease. Assuring world class products at affordable prices is the hall mark of POLYMED

Product range of the company:

The company manufactures different products related to :

Infusion Therapy
Central Venous Access Catheters
Anaesthesia
Urology
Gastroenterology
Blood Management
Surgery & Wound Drainage
Dialysis
Others

Achievements/ recognition:

QMS (Quality Management System) accredited by SGS
ISO 9001:2000
ISO-13485:2003
CE mark from DNV
US FDA 510k approved

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Poly Medicure Ltd (POLYMED) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Poly Medicure Share Price